Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio

Fig. 2

Outcomes of patients divided according to the Milan and Hangzhou criteria. The patients were divided into in-Milan group, Milan ~ Hangzhou group, and out-Hangzhou group. The 1-, 3-, and 5-year RFS of patients in the out-Hangzhou group were significantly worse than the other two groups. The RFS of the Milan ~ Hangzhou group were less than that of the in-Milan group, but no statistically significant difference was presented

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us